CAPNOLINE
Device
COVIDIEN LP
Total Payments
$1.2M
Transactions
74
Doctors
11
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $1.2M | 74 | 11 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.2M | 74 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PRODIGY | COVIDIEN LP | $964,732 | 8 |
| CAPNOGRAPHY AT THE BEDSIDE | COVIDIEN LP | $76,740 | 1 |
| USE OF INTEGRATED PULMONARY INDEX TO PREDICT POST-OPERATIVE RESPIRATORY | COVIDIEN LP | $45,530 | 0 |
| CAPNOGRAPHY GFC | COVIDIEN LP | $44,489 | 2 |
| CAPNOGRAPHY FILTERLINES | COVIDIEN LP | $19,315 | 0 |
| FRS | COVIDIEN LP | $16,964 | 0 |
| INVESTIGATOR SPONSORED RESEARCH | COVIDIEN LP | $7,950 | 0 |
| PRELIMINARY CHARACTERIZATION OF THE CAPNOGRAPHY PROFILE OF OBSTRUCTIVE SLEEP APNEA | COVIDIEN LP | $5,276 | 0 |
Top Doctors Receiving Payments for CAPNOLINE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Louisville, CO | $959,320 | 47 |
| , MD | Pediatric Emergency Medicine | New Haven, CT | $67,705 | 1 |
| , MD | Surgery | Aurora, CO | $56,186 | 1 |
| , MD | Pulmonary Disease | Cleveland, OH | $30,320 | 5 |
| , M.D | Anesthesiology | Nashville, TN | $22,995 | 7 |
| , M.D | Anesthesiology | Royal Oak, MI | $14,047 | 2 |
| , M.D | Anesthesiology | Rochester, MN | $12,529 | 1 |
| , M.D | Critical Care Medicine | Nashville, TN | $8,413 | 5 |
| , M.D | Anesthesiology | Ann Arbor, MI | $4,805 | 1 |
| , M.D | Critical Care Medicine | Cleveland, OH | $3,695 | 1 |
| , M.D | Anesthesiology | Everett, WA | $610.00 | 2 |
| , MD | Anesthesiology | Columbus, OH | $370.00 | 1 |
Ad
Manufacturing Companies
- COVIDIEN LP $1.2M
Product Information
- Type Device
- Total Payments $1.2M
- Total Doctors 11
- Transactions 74
About CAPNOLINE
CAPNOLINE is a device associated with $1.2M in payments to 11 healthcare providers, recorded across 74 transactions in the CMS Open Payments database. The primary manufacturer is COVIDIEN LP.
Payment data is available from 2018 to 2018. In 2018, $1.2M was paid across 74 transactions to 11 doctors.
The most common payment nature for CAPNOLINE is "Unspecified" ($1.2M, 100.0% of total).
CAPNOLINE is associated with 8 research studies, including "PRODIGY" ($964,732).